Covid vaccine patent landscape heats up as Pfizer’s partner sues Arbutus and Genevant – Endpoints News
Covid vaccine patent landscape heats up as Pfizer’s partner sues Arbutus and Genevant Endpoints News
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Patent Analytics Market Key Drivers in 2022, Regional Investments, Top Competitors and Industry Share – ChattTenn Sports – ChattTenn Sports
Patent Analytics Market Key Drivers in 2022, Regional Investments, Top Competitors and Industry Share – ChattTenn Sports ChattTenn Sports
-
In: PATENT NEWS
G81 BMW M3 Touring Design Patent Reveals High-Performance Station Wagon – autoevolution
G81 BMW M3 Touring Design Patent Reveals High-Performance Station Wagon autoevolution
-
In: PATENT NEWS
OSE Immunotherapeutics Receives First Notice of Allowance for a US Patent Covering Anti-PD1 Monoclonal Antibody OSE-279 And its Use in Cancer Treatment – Yahoo Finance
OSE Immunotherapeutics Receives First Notice of Allowance for a US Patent Covering Anti-PD1 Monoclonal Antibody OSE-279 And its Use in Cancer Treatment Yahoo Finance
-
In: PATENT NEWS
Longi wants to challenge recent ruling in patent dispute with Hanwha Q-Cells in the Netherlands – pv magazine International
Longi wants to challenge recent ruling in patent dispute with Hanwha Q-Cells in the Netherlands pv magazine International
-
In: PATENT NEWS
Ford Patent Filed For Augmented Reality System With Sharing Capability – Ford Authority
Ford Patent Filed For Augmented Reality System With Sharing Capability Ford Authority
-
In: PATENT NEWS
Bardy Diagnostics Files Patent Infringement Case Over Electrocardiography Monitor – Law Street Media
Bardy Diagnostics Files Patent Infringement Case Over Electrocardiography Monitor Law Street Media
-
In: PATENT NEWS
COVID patent waiver ‘solution’ is unworkable and won’t make enough difference for developing countries – Medical Xpress
COVID patent waiver ‘solution’ is unworkable and won’t make enough difference for developing countries Medical Xpress
-
In: PATENT NEWS
Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suit – FiercePharma
Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suit FiercePharma
-
In: PATENT NEWS
Roquefort Therapeutics patent filing for new class of midkine-targeting drugs is “crucial milestone” – Proactive Investors UK
Roquefort Therapeutics patent filing for new class of midkine-targeting drugs is “crucial milestone” Proactive Investors UK